Evidence map›Paper›PMID 37313235›Full record

ArticleTouchREVIEWS in endocrinology2023

Surgical Treatment of Solitary Metachronous Adrenal Metastasis from Urothelial Carcinoma of the Urinary Bladder.

Dimitrios Politis, Panagiota Konstantakou, Konstantinos Bramis, Krystallenia I Alexandraki, Ariadni Spyroglou, George Mastorakos, Ioannis Anastasiou, Ioannis Papaconstantinou, Meletios A Dimopoulos

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in TouchREVIEWS in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dimitrios PolitisSecond Department of Surgery, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Panagiota KonstantakouEndocrinology Department, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Konstantinos BramisSecond Department of Surgery, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Krystallenia I AlexandrakiEndocrinology Department, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Ariadni SpyroglouEndocrinology Department, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
George MastorakosEndocrinology Department, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Ioannis AnastasiouFirst Department of Urology, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece.
Ioannis PapaconstantinouSecond Department of Surgery, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Meletios A DimopoulosDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urothelial cancer is a common neoplasm and metastatic disease correlates with a poor prognosis. Isolated adrenal gland metastases of urothelial carcinoma are quite rare, and management options can decide a patient's prognosis. Herein we report the case of a 76-year-old man with a metachronous solitary adrenal metastasis from a bladder carcinoma, who underwent adrenalectomy as part of his treatment. Furthermore, we discuss the cases of solitary adrenal metastases of urothelial carcinoma available in the literature, to identify key features to direct appropriate treatment of this rare metastatic site of urothelial cancer and improve prognosis and survival. Still, further prospective studies are needed to design effective therapeutic strategies.

Indexed as

adrenalectomyAdrenal metastasismetastatic urothelial bladder carcinomametastatic urothelial carcinomasurgical treatment of adrenal metastasisurothelial carcinoma

Identifiers

PMID37313235
PMCPMC10258614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.